GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. 

The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.

Therapeutics

Pharmaceutical

Life Sciences

Biotechnology

GC Therapeutics

Parastoo Khoshakhlagh

Cory Smith

Alex Ng

Kathryn Swiderski

Muhan Li

The Scientific Research and Development team at GC Therapeutics is responsible for advancing the company's synthetic biology technology by experimenting with and optimizing patient-derived stem cells. They focus on efficiently programming these cells into various types required for different medical applications, including the tailored development of SuperCells™ for specific diseases. Their work ensures high efficiency, speed, and scalability in cell therapy applications, playing a critical role in translating biotechnological innovations into viable treatments for patients.

Scientific Research and Development

Leadership Team

Scientific Research and Development

About

Team members

Other teams at GC Therapeutics

Leadership Team